To the incompatibility of haloperidol with lithium salts.
D000293:Adolescent; D001714:Bipolar Disorder / Q000188:drug therapy; D004344:Drug Incompatibility; D004359:Drug Therapy, Combination; D005260:Female; D006220:Haloperidol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007022:Hypotension / Q000139:chemically induced*; D008607:Intellectual Disability / Q000188:drug therapy; D008094:Lithium / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced*; D010468:Perceptual Disorders / Q000139:chemically induced*; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy; D013064:Speech Disorders / Q000139:chemically induced*
D008094:Lithium; D006220:Haloperidol